INHIBITION OF METOPROLOL METABOLISM BY CHLOROQUINE AND OTHER ANTIMALARIAL-DRUGS

被引:30
作者
LANCASTER, DL [1 ]
ADIO, RA [1 ]
TAI, KK [1 ]
SIMOOYA, OO [1 ]
BROADHEAD, GD [1 ]
TUCKER, GT [1 ]
LENNARD, MS [1 ]
机构
[1] UNIV SHEFFIELD, ROYAL HALLAMSHIRE HOSP, DEPT MED & PHARMACOL, SHEFFIELD S10 2JF, S YORKSHIRE, ENGLAND
基金
英国惠康基金;
关键词
D O I
10.1111/j.2042-7158.1990.tb05405.x
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Abstract— The ability of a series of antimalarial drugs to impair the metabolism of metoprolol in rat and man has been examined. Chloroquine was a potent inhibitor in rat liver microsomes (Kj value for metoprolol α‐hydroxylation = 0.18 μM and for O‐demethylation = 0.36 μM). The other antimalarial drugs also inhibited metoprolol oxidation. Quinine was similar to chloroquine in potency, while quinidine, primaquine and mefloquine were slightly less potent. Chloroquine also inhibited metoprolol oxidation in human liver microsomes, although it was about two orders of magnitude less potent than in the rat and the extent of impairment varied greatly between individual livers. Intraperitoneal administration of chloroquine to anaesthetized rats decreased the clearance of metoprolol (40 mg tartrate salt kg−1 i.p.) to 54, 34, 20 and 26% of the control value at doses of 2.5, 4.0, 25 and 40 mg kg−1, respectively. We conclude that antimalarial treatment might have contributed to a previously reported difference in the metabolic pattern of metoprolol between Caucasians and Nigerians. 1990 Royal Pharmaceutical Society of Great Britain
引用
收藏
页码:267 / 271
页数:5
相关论文
共 21 条
[1]
AYITEYSMITH E, 1980, ARCH INT PHARMACOD T, V243, P192
[2]
BORG KO, 1975, ACTA PHARMACOL TOX, V36, P125
[3]
EXPRESSION OF A HUMAN-LIVER CYTOCHROME-P-450 PROTEIN WITH TOLBUTAMIDE HYDROXYLASE-ACTIVITY IN SACCHAROMYCES-CEREVISIAE [J].
BRIAN, WR ;
SRIVASTAVA, PK ;
UMBENHAUER, DR ;
LLOYD, RS ;
GUENGERICH, FP .
BIOCHEMISTRY, 1989, 28 (12) :4993-4999
[4]
Cornish-Bowden A., 1979, FUNDAMENTALS ENZYME, P82
[5]
CHARACTERIZATION OF THE COMMON GENETIC-DEFECT IN HUMANS DEFICIENT IN DEBRISOQUINE METABOLISM [J].
GONZALEZ, FJ ;
SKODA, RC ;
KIMURA, S ;
UMENO, M ;
ZANGER, UM ;
NEBERT, DW ;
GELBOIN, HV ;
HARDWICK, JP ;
MEYER, UA .
NATURE, 1988, 331 (6155) :442-446
[6]
METOPROLOL AND DEBRISOQUIN METABOLISM IN NIGERIANS - LACK OF EVIDENCE FOR POLYMORPHIC OXIDATION [J].
IYUN, AO ;
LENNARD, MS ;
TUCKER, GT ;
WOODS, HF .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (04) :387-394
[7]
PURIFICATION AND CHARACTERIZATION OF THE RAT-LIVER MICROSOMAL CYTOCHROME-P-450 INVOLVED IN THE 4-HYDROXYLATION OF DEBRISOQUINE, A PROTOTYPE FOR GENETIC-VARIATION IN OXIDATIVE DRUG-METABOLISM [J].
LARREY, D ;
DISTLERATH, LM ;
DANNAN, GA ;
WILKINSON, GR ;
GUENGERICH, FP .
BIOCHEMISTRY, 1984, 23 (12) :2787-2795
[8]
METOPROLOL OXIDATION BY RAT-LIVER MICROSOMES - INHIBITION BY DEBRISOQUINE AND OTHER DRUGS [J].
LENNARD, MS ;
CREWE, HK ;
TUCKER, GT ;
WOODS, HF .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (16) :2757-2761
[9]
RAPID-DETERMINATION OF METOPROLOL AND ALPHA-HYDROXYMETOPROLOL IN HUMAN-PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
LENNARD, MS ;
SILAS, JH .
JOURNAL OF CHROMATOGRAPHY, 1983, 272 (01) :205-209
[10]
QUANTITATIVE-ANALYSIS OF METOPROLOL AND 3 OF ITS METABOLITES IN URINE AND LIVER-MICROSOMES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
LENNARD, MS .
JOURNAL OF CHROMATOGRAPHY, 1985, 342 (01) :199-205